Science Explorer Back to mapMap
Discussion
Company · Novato · United States

Cytograft Tissue Engineering (United States)

Research works
88
▼ 80% vs 2018-21
Citations
1k
11.8 per fractional work
Top-10% rate
34.5%
all institutions 10.0%
Open access
18%
world 40%
International
18%
world 18%
Cytograft Tissue Engineering (United States)

Not ranked overall: Cytograft Tissue Engineering (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Cytograft Tissue Engineering (United States) work in?

In all years, 45% of research at Cytograft Tissue Engineering (United States) is in Health Sciences, 41% in Physical Sciences. Its largest fields are Medicine (43%), Engineering (20%), Materials Science (17%). It does 1.8× the world's share of Health Sciences.

Health Sciences: 40 fractional works · 45.0% of its workMedicine: 38 fractional works · 43.3% of its workSurgery: 16 fractional works · 18.1% of its workCardiology and Cardiovascular Medicine: 9 fractional works · 9.8% of its workOncology: 2 fractional works · 2.1% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 2.1% of its workEpidemiology: 2 fractional works · 2.0% of its workPulmonary and Respiratory Medicine: 2 fractional works · 1.9% of its workPhysiology: 2 fractional works · 1.8% of its workRheumatology: 1 fractional works · 0.8% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.6% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.6% of its workNeurology: 0 fractional works · 0.6% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.6% of its workRehabilitation: 0 fractional works · 0.6% of its workImmunology and Allergy: 0 fractional works · 0.4% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.4% of its workPathology and Forensic Medicine: 0 fractional works · 0.4% of its workSmaller subfields together: 1 fractional works · 0.6% of its workHealth Professions: 2 fractional works · 1.7% of its workOccupational Therapy: 1 fractional works · 1.1% of its workEmergency Medical Services: 0 fractional works · 0.6% of its workPhysical Sciences: 36 fractional works · 40.9% of its workEngineering: 18 fractional works · 20.0% of its workBiomedical Engineering: 9 fractional works · 10.3% of its workMechanical Engineering: 3 fractional works · 3.9% of its workMechanics of Materials: 2 fractional works · 2.3% of its workControl and Systems Engineering: 1 fractional works · 0.9% of its workAerospace Engineering: 1 fractional works · 0.8% of its workCivil and Structural Engineering: 1 fractional works · 0.8% of its workElectrical and Electronic Engineering: 0 fractional works · 0.6% of its workComputational Mechanics: 0 fractional works · 0.4% of its workMaterials Science: 15 fractional works · 17.1% of its workBiomaterials: 13 fractional works · 15.1% of its workPolymers and Plastics: 1 fractional works · 1.6% of its workMaterials Chemistry: 0 fractional works · 0.4% of its workChemical Engineering: 1 fractional works · 1.5% of its workFluid Flow and Transfer Processes: 1 fractional works · 1.5% of its workComputer Science: 1 fractional works · 1.2% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.6% of its workArtificial Intelligence: 0 fractional works · 0.4% of its workComputational Theory and Mathematics: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 1 fractional works · 1.1% of its workGeophysics: 1 fractional works · 1.1% of its workLife Sciences: 12 fractional works · 13.7% of its workBiochemistry, Genetics and Molecular Biology: 10 fractional works · 11.6% of its workCell Biology: 5 fractional works · 5.3% of its workMolecular Biology: 4 fractional works · 4.4% of its workMolecular Medicine: 1 fractional works · 1.3% of its workGenetics: 0 fractional works · 0.6% of its workImmunology and Microbiology: 1 fractional works · 1.2% of its workImmunology: 1 fractional works · 1.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.6% of its workPlant Science: 0 fractional works · 0.6% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.4% of its workPharmaceutical Science: 0 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 0.4% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.4% of its workEconomics and Econometrics: 0 fractional works · 0.4% of its workALL ITS WORKCytograft TissueEngineering…88fractional works, all years
Life Sciences14%Physical Sciences41%Health Sciences45%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Medicine3843.3%
    2. Health Professions21.7%
    1. Engineering1820.0%
    2. Materials Science1517.1%
    3. Chemical Engineering11.5%
    4. Computer Science11.2%
    5. Earth and Planetary Sciences11.1%
    1. Biochemistry, Genetics and Molecular Biology1011.6%
    2. Immunology and Microbiology11.2%
    3. Agricultural and Biological Sciences00.6%
    4. Pharmacology, Toxicology and Pharmaceutics00.4%
    1. Economics, Econometrics and Finance00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Cytograft Tissue Engineering (United States)?

Ranked on the quality score, Todd N. McAllister, Sergio A. Garrido and DL Dan Bader lead among researchers whose main affiliation is Cytograft Tissue Engineering (United States).

  1. 1 Todd N. McAllister United States · #273,736 worldwide 4.5k citations · 40 works
  2. 2 Sergio A. Garrido United States · #1,112,555 worldwide 1.6k citations · 20 works
  3. 3 DL Dan Bader United States · #4,500,770 worldwide 26 citations · 19 works
  4. 4 K Klaas Nicolaij United States · #4,910,000 worldwide 15 citations · 24 works
  5. 5 SP Simon Hoerstrup United States · #5,420,259 worldwide 11 citations · 33 works
  6. 6 Fpt Frank Baaijens United States · #6,223,778 worldwide 48 citations · 71 works
All ranked researchers at Cytograft Tissue Engineering (United States)

What are the most cited papers from Cytograft Tissue Engineering (United States)?

The most cited paper from Cytograft Tissue Engineering (United States) is "Human tissue-engineered blood vessels for adult arterial revascularization" (Nicolas L’Heureux, Nathalie Dusserre, Gerhardt König et al., 2006), with 1,081 citations. Next come "Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery" (584) and "Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study" (509).

Most cited papers
#PaperReleasedCitations
1 Human tissue-engineered blood vessels for adult arterial revascularization Nicolas L’Heureux, Nathalie Dusserre, Gerhardt König et al. · Nature Medicine Open access 19 Feb 2006 1,081
2 Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery Gerhardt König, Todd N. McAllister, Nathalie Dusserre et al. · Biomaterials Open access 26 Dec 2008 584
3 Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study Todd N. McAllister, Marcin Maruszewski, Sergio A. Garrido et al. · The Lancet Apr 2009 509
4 Technology Insight: the evolution of tissue-engineered vascular grafts—from research to clinical practice Nicolas L’Heureux, Nathalie Dusserre, Alicia Marini et al. · Nature Clinical Practice Cardiovascular Medicine 22 Jun 2007 297
5 First human use of an allogeneic tissue-engineered vascular graft for hemodialysis access Wojciech Wystrychowski, Todd N. McAllister, Krzysztof Zagalski et al. · Journal of Vascular Surgery Open access 5 Oct 2013 200
All 70 most cited papers, with filters and sorting

Which keywords describe research at Cytograft Tissue Engineering (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Regenerative Medicine, Tissue Engineering, Extracellular Matrix, Biomedical Applications, Drug Delivery, Nanocomposites, Electrospinning and Nanofibers.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Regenerative Medicine27▲ 142×5 topics
  2. Tissue Engineering22▲ 47×6 topics
  3. Extracellular Matrix15▲ 73×4 topics
  4. Biomedical Applications15▲ 16×6 topics
  5. Drug Delivery13▲ 32×2 topics
  6. Nanocomposites12▲ 18×2 topics
  7. Electrospinning12▲ 256×1 topic
  8. Nanofibers12▲ 77×1 topic
  9. Stem Cell Therapy9▲ 111×2 topics
  10. Decellularization9▲ 281×1 topic
  11. Organ Engineering9▲ 281×1 topic
  12. Surgical Aortic-Valve Replacement6▲ 100×1 topic
  13. Transcatheter Aortic-Valve Replacement6▲ 100×1 topic
  14. Biomechanics6▲ 19×3 topics
  15. Stem Cells5▲ 20×3 topics
  16. Cell Mechanics5▲ 156×1 topic
  17. Mechanotransduction5▲ 52×1 topic
  18. Cell Culture4▲ 45×2 topics
  19. Hydrogels4▲ 37×2 topics
  20. Finite Element Analysis4▲ 20×4 topics
  21. Arterial Biomechanics4▲ 172×1 topic
  22. Hyperelastic Modeling4▲ 172×1 topic
  23. Inflammatory Response4▲ 52×2 topics
  24. Bioprinting3▲ 80×1 topic
  25. Microfluidic Devices3▲ 44×1 topic
  26. Macrophages3▲ 18×3 topics
  27. Wnt Signaling3▲ 25×2 topics
  28. Heart Failure3▲ 6.5×4 topics
  29. Cardiomyocyte Renewal2▲ 107×1 topic
  30. Endovascular Repair2▲ 32×3 topics
  31. Heart Regeneration2▲ 107×1 topic
  32. Cardiopulmonary Bypass2▲ 96×1 topic
  33. Coronary Artery Bypass Surgery2▲ 96×1 topic
  34. Biomaterials2▲ 12×3 topics
  35. Cancer Immunotherapy2▲ 18×2 topics
  36. Echocardiography2▲ 9.0×3 topics
  37. Ductile Fracture2▲ 57×1 topic
  38. Sheet Metal Forming2▲ 57×1 topic
  39. Hypertrophy2▲ 33×2 topics
  40. Rheology2▲ 9.7×2 topics

Which research topics does Cytograft Tissue Engineering (United States) publish most on?

By volume in 2022-now: Medical Imaging and Pathology Studies, Heterotopic Ossification and Related Conditions, Parathyroid Disorders and Treatments and Infectious Aortic and Vascular Conditions.

  1. 1 Medical Imaging and Pathology Studies Pulmonary and Respiratory Medicine 0 works
  2. 2 Heterotopic Ossification and Related Conditions Rheumatology 0 works
  3. 3 Parathyroid Disorders and Treatments Nephrology 0 works
  4. 4 Infectious Aortic and Vascular Conditions Surgery 0 works
  5. 5 Central Venous Catheters and Hemodialysis Emergency Medical Services 0 works
  6. 6 Dialysis and Renal Disease Management Nephrology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available18.3%not open81.7%

World: 40% of research is openly available.

with international co-authors17.5%domestic only82.5%

World: 18% is written across borders.

How has Cytograft Tissue Engineering (United States)'s research output changed?

Output in 2022-2025 was 80% lower than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Cytograft Tissue Engineering (United States) as a percentage of every work published that year, 0.0000025% in 2022.

still counting0.00020%0.00040%Cytograft Tissue Engineering (United States)0.0000029% in 2025200020102020

Fractional works of Cytograft Tissue Engineering (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Novato

All research institutions in Novato

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Cytograft Tissue Engineering (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.